Merck Novartis Merck and Novartis Financial Statements Essay

Open, View, and/or
Download this Document

Total Length: 638 words ( 2 double-spaced pages)

Total Sources: 3

Page 1 of 2

Merck Novartis

Merck and Novartis Financial Statements 2012

Balance Sheet

• What components of stockholders' equity do each of the companies disclose?

Merck & Co. provides a consolidated statement of stockholders equity on their balance sheet. They disclose the number of shares, share types, retained earnings, and some historical data (Merck & Co., 2013).

Novartis provides a much more thorough and detailed report of their shareholders equity in their annual report. Not only do they report all of the same accounts as Merck, but they also provide a detailed analysis of the movements in shareholders' equity as well as many of the motivations that are responsible for changes (Novartis, 2013)

• Do the companies have preferred stock shares outstanding? If so, what special features do these shares contain?

Both companies have preferred stock. Preferred stock accounts are paid before the common stock accounts. They are given priority when there is a decision to be made about who gets paid first and how much.

• Do either of the companies report treasury shares? If so, do the companies disclose the reason for reacquiring the shares?

Both companies report treasury shares.

Stuck Writing Your "Merck Novartis Merck and Novartis Financial Statements" Essay?

View All Our Example Merck Novartis Merck and Novartis Financial Statements Essay

Have A Custom Example Essay Written

Novartis received some treasury shares when it merged with Alcon as report on their financial statements (Novartis, 2013). Merck discloses their treasury holdings, however they do not discuss motivations for such on their report.

Income Statement

• What are the basic and diluted earnings per share for each company?

Merck - $3.82

Novartis - $5.25

• Have the companies reported any discontinued operations?

Yes. Merck has went through a series of cost reduction programs. As of the end of 2012 for example, Merck had achieved its projected $3.5 billion in annual net cost savings from these activities since the merger with Schering-Plough Corporation. Novartis seemed to focus more on acquisitions than cost reduction measures.

• Do the companies disclose any stock compensation plans? If so, are they reporting such plans….....

Show More ⇣

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Merck Novartis Merck And Novartis Financial Statements" (2013, August 29) Retrieved June 7, 2026, from
https://www.aceyourpaper.com/essays/merck-novartis-merck-novartis-financial-95367

Latest MLA Format (8th edition)

Copy Reference
"Merck Novartis Merck And Novartis Financial Statements" 29 August 2013. Web.7 June. 2026. <
https://www.aceyourpaper.com/essays/merck-novartis-merck-novartis-financial-95367>

Latest Chicago Format (16th edition)

Copy Reference
"Merck Novartis Merck And Novartis Financial Statements", 29 August 2013, Accessed.7 June. 2026,
https://www.aceyourpaper.com/essays/merck-novartis-merck-novartis-financial-95367
   

Open, View, and/or
Download this Document
order custom essay example